Page 30 - Central Drug Authority Annual Report 2021

9. RULES OF THE CDA

7KH $FW UHTXLUHV WKDW WKH &'$ GUDIW UXOHV JRYHUQLQJ WKH E 7KH DOORFDWLRQ GHOHJDWLRQ DQG PRQLWRULQJ RI GXWLHV DQG
ȟFRQGXFW RI LWV IXQFWLRQVȠ 7R EH HIIHFWLYH WKH UXOHV PXVW EH UHVSRQVLELOLWLHV RI PHPEHUV RI WKH &'$ DSSRLQWHG DV
DSSURYHG E\ WKH 0LQLVWHU DQG SXEOLVKHG LQ WKH UHTXLVLWH H[SHUWV DQG SHUIRUPDQFH DJUHHPHQWV OLQNHG WKHUHWR
*RYHUQPHQW *D]HWWH 7KH ODVW UHYLHZ ZDV LQ F 'LVFLSOLQDU\ DXWKRULW\ DQG SURFHGXUHV DSSOLFDEOH WR
PHPEHUV RI WKH &'$ DQG WKH VXSSRUWLQJ LQIUDVWUXFWXUH
([SHULHQFH KDV VKRZQ WKDW WKHVH UXOHV ZKLFK GLIIHU IURP 36$)ȠV DQG /'$&ȠV
WKRVH RULJLQDOO\ SURSRVHG E\ WKH &'$ GR QRW DXWKRUL]H WKH G 'HYHORSPHQW VXEPLVVLRQ H[HFXWLRQ DQG PRQLWRULQJ
&'$ WR FRQGXFW LWV IXQFWLRQV HIIHFWLYHO\ %HDULQJ LQ PLQG WKDW DQG HYDOXDWLRQ RI WKH 'HSDUWPHQWDO DQG 3URYLQFLDO 'UXJ
WKH &'$ LV QRW HQWLWOHG WR SXEOLVK UHJXODWLRQV WKHVH UXOHV 0DVWHU 3ODQV IRUPHUO\ 0LQL '03ȠV
QHHG XUJHQW UHYLVLRQ VR DV WR SURYLGH WKH &'$ ZLWK WKH H 5HSRUWV DQG UHSRUWLQJ SURFHGXUHV E\ DQG WR WKH &'$
DXWKRULW\ QHHGHG WR FRQGXFW LWV IXQFWLRQV HIIHFWLYHO\ WKDW HQDEOH WKH &'$ WR PHHW LWV REOLJDWLRQV WR WKH
$VSHFWV UHTXLULQJ UHYLVLRQ DQG RU LQFOXVLRQ LQ D QHZ VHW RI 0LQLVWHU DQG 3DUOLDPHQW LQ WHUPV RI UHSRUWV DGYLFH DQG
UXOHV LQFOXGH EXW VKRXOG QRW EH OLPLWHG WR the CDA Annual Report.

D 7KH DOORFDWLRQ GHOHJDWLRQ DQG PRQLWRULQJ RI GXWLHV DQG
UHVSRQVLELOLWLHV WR DQG WKHLU SHUIRUPDQFH E\ PHPEHUV RI WKH
&'$ DQG LWV VXSSRUWLQJ VWUXFWXUHV 36$)ȠV DQG /'$&ȠV LQ
JLYLQJ HIIHFW WR WKH 1'03 DQG WKH $FW &KDSWHU RI $FW
RI SURYLGHV IRU VHWWLQJ XS RI GHSDUWPHQWDO SURYLQFLDO
DQG LQGLYLGXDO SHUIRUPDQFH DVVHVVPHQW SURFHGXUHV DQG RU
FRQWUDFWV IRU JRYHUQPHQW HPSOR\HHV DSSRLQWHG WR WKH &'$
DQG IRU WKHLU GXWLHV LQ WKH &'$

10. SUPPORTING STRUCTURES OF THE CDA

7KH PDQGDWH RI WKH &'$ FOHDUO\ LQGLFDWHV WKDW LW LV QRW DQ 7KH UHSUHVHQWDWLRQ RI GHSDUWPHQWV LQ 3URYLQFLDO 6XEVWDQFH
LPSOHPHQWLQJ ERG\ L H LW GRHV QRW RI LWVHOI LPSOHPHQW WKH $EXVH )RUXPV ZDV YHU\ SRRU 7KH 36$) V ZHUH VXVWDLQHG
1'03 EXW GLUHFWV FR RUGLQDWHV FRQWUROV PRQLWRUV DQG PRUH E\ WKH 'HSDUWPHQW RI 6RFLDO 'HYHORSPHQW DQG H[SHUWV
HYDOXDWHV WKH SURJUDPV DQG DFWLYLWLHV RI LWV LPSOHPHQWLQJ RQ VXEVWDQFH DEXVH 7KH SURYLQFHV DQG PXQLFLSDOLWLHV ZHUH
DJHQFLHV QRW GRLQJ HQRXJK WR SURYLGH UHVRXUFHV RU WR VXSSRUW WKH
ZRUN RI 36$) V DQG /'$& V
,PSOHPHQWDWLRQ LV WKHUHIRUH OHIW WR WKH QDWLRQDO GHSDUW-
PHQWV WKH 3URYLQFLDO 6XEVWDQFH $EXVH )RUXPV 36$)ȠV DQG *LYHQ WKH LQWHUQDWLRQDO QDWXUH RI WKH GUXJ SUREOHP WKH
WKHLU /RFDO 'UXJ $FWLRQ &RPPLWWHHV /'$&ȠV DV ZHOO DV VXEVWDQFH DEXVH SUREOHP LWV H[WHQW LWV FKDQJLQJ QDWXUH
1RQ *RYHUQPHQWDO 2UJDQLVDWLRQV 1*2ȠV DQG WKH PDVVLYH ELRORJLFDO VRFLDO DQG HFRQRPLF LPSDFW RQ
6RXWK $IULFD LW LV YLWDO WKDW PHPEHUV RI WKH &'$ DQG LWV
&KDSWHU RI WKH $FW $FW RI SURYLGHV PRUH GHWDLO VXSSRUWLQJ VWUXFWXUHV EH HPSRZHUHG RQ DQ RQJRLQJ EDVLV
RQ WKH VWUXFWXUH DQG SURFHVVHV WKDW PXVW EH LQ SODFH WR ZLWK WKH NQRZOHGJH VNLOOV DQG YDOXHV QHFHVVDU\ WR FRPEDW
VXSSRUW WKH ZRUN RI WKH &'$ 7KH $FW IXUWKHU VWLSXODWHV WKH WKH VXEVWDQFH DEXVH SUREOHP DQG SURYLGHG ZLWK WKH
UHVRXUFHV UHTXLUHG WR VXSSRUW WKH HIIHFWLYH IXQFWLRQLQJ RI UHVRXUFHV ˉQDQFLDO KXPDQ DQG PDWHULDO QHHGHG WR GR VR
WKH &'$ DW SURYLQFLDO DQG ORFDO OHYHO DQG WKH SURYLVLRQ RI HIIHFWLYHO\
VXFK UHVRXUFHV LV WKH UHVSRQVLELOLW\ RI SURYLQFLDO JRYHUQ-
PHQWV DV ZHOO DV PXQLFLSDOLWLHV

28 Annual Report 2020/2021 Central Drug Authority